Skip to content

Assessment of Intracerebral Hematoma

Assessment of Intracerebral Hematoma Using Transcranial Duplex _ Hospital Based Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05158660
Enrollment
120
Registered
2021-12-15
Start date
2022-01-31
Completion date
2023-01-31
Last updated
2021-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hematoma

Brief summary

The study will assess acute intracerebral hematoma expansion within the first 48 hours from the onset using transcranial duplex sonography in patients who have acute intracerebral hematoma , and will also assess the correlation between the transcranial duplex sonography measurements and the clinical outcome of these patients .

Interventions

it is an imaging device that will measure the intracerebral hematoma expansion

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. first ever non traumatic supratentorial primary intracerebral haemorrhage on non contrast CT brain 2. admitted within 24 hours of symptom onset

Exclusion criteria

1. blood diseases, decompansated hepatic or renal impairment, or encephalopathy caused by electrolyte disturbance 2. on anticoagulant treatment 3. if devolped major complications during hospitalization ( e.g sever chest infection, hypoxia, or deep venous thrombosis ) 4. comorbid neurological or psychiatric disorders

Design outcomes

Primary

MeasureTime frame
change from baseline in volume of intracerebral hematomaat baseline, then 24 hour after the baseline, and finally 48 hours after the baseline

Contacts

Primary Contactwaleed Gafar
waleed.gafar1995@gmail.com00201012110708

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026